Search results for "phlebotomy"

showing 9 items of 9 documents

Immunoglobulin A response to acute stress in intimate partner violence perpetrators: the role of anger expression-out and testosterone.

2014

Aggressive behavior and immune activity are shown to be positively associated in perpetrators of intimate partner violence (IPV). This relationship follows an inverted-U curve, with the most violent individuals showing lower levels of immunocompetence than those with a history of moderate violence. Moreover, the activational and organizational effects of testosterone (T) may indirectly stimulate the immune response. Given this, we used the Trier Social Stress Test to establish whether the salivary immunoglobulin A (sIgA) response to acute stress was a specific psychobiological feature in perpetrators of intimate partner violence (IPV). IPV perpetrators showed higher sIgA levels than control…

AdultMaleDigit ratiomedicine.medical_specialtyStatistics as TopicPoison controlbehavioral disciplines and activitiesSuicide preventionFingersYoung AdultPhlebotomymental disordersInjury preventionmedicineTrier social stress testHumansInterpersonal RelationsTestosteronePsychiatrySalivaAnalysis of VariancePsychological TestsGeneral NeuroscienceHuman factors and ergonomicsTestosterone (patch)social sciencesMiddle AgedImmunoglobulin AAggressionNeuropsychology and Physiological PsychologyArea Under CurveCase-Control StudiesDomestic violencePsychologyStress PsychologicalClinical psychologyBiological psychology
researchProduct

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial.

2021

Summary Background There is no evidence that phlebotomy alone is sufficient to steadily maintain haematocrit on target level in low-risk patients with polycythaemia vera. This study aimed to compare the efficacy and safety of ropeginterferon alfa-2b on top of the standard phlebotomy regimen with phlebotomy alone. Methods In 2017, we launched the Low-PV study, a multicentre, open-label, two-arm, parallel-group, investigator-initiated, phase 2 randomised trial with a group-sequential adaptive design. The study involved 21 haematological centres across Italy. Participants were recruited in a consecutive order. Participants enrolled in the study were patients, aged 18–60 years, with a diagnosis…

AdultMalemedicine.medical_specialtyPolycythaemiaNeutropeniaAdolescentPolicithemia veraInterferon alpha-2Polymorphism Single Nucleotidelaw.inventionPolyethylene Glycols03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled trialPhlebotomylawBone MarrowInternal medicinemedicineClinical endpointData monitoring committeeHumansPolycythemia Verabusiness.industryStandard treatmentInterferon-alphaHematologyPhlebotomyJanus Kinase 2Middle AgedInterim analysismedicine.diseaseRecombinant ProteinsRegimenTreatment Outcome030220 oncology & carcinogenesisQuality of LifeFemalebusiness030215 immunologyThe Lancet. Haematology
researchProduct

A case of severe dermatitis in a patient with Polycythemia Vera during cytoreductive therapy

2019

Polycythemia Vera (PV) is a Philadelphia-negative chronic myeloproliferative neoplasm (MPN) mainly characterized by erythrocytosis. In this report we describe a case of severe cutaneous toxicity in patients with PV treated with hydroxyurea. A 72-year-old woman diagnosed with PV with V617F mutation of JAK2 performed more than 10 years before and treated with hydroxyurea plus phlebotomies and low-dose ASA for about 7 years addressed our center for the appearance of serious dermatitis at the face symptomatic for severe itch. The patient underwent a dermatology visit with diagnosis of desquamative dermatitis due to iatrogenic cause related to the use of hydroxyurea. HU was stopped for a month w…

Adverse eventmedicine.medical_specialtybusiness.industryCutaneous toxicityGeneral MedicinePhlebotomymedicine.diseaseDermatologyDermatitiPolycythemia veraSettore MED/15 - Malattie Del SanguePolycythemia verahemic and lymphatic diseasesChronic Myeloproliferative NeoplasmmedicineHydroxyureaIn patientbusiness
researchProduct

Cardiovascular events and intensity of treatment in polycythemia vera.

2013

A b s t r ac t Background Current treatment recommendations for patients with polycythemia vera call for maintaining a hematocrit of less than 45%, but this therapeutic strategy has not been tested in a randomized clinical trial. Methods We randomly assigned 365 adults with JAK2-positive polycythemia vera who were being treated with phlebotomy, hydroxyurea, or both to receive either more intensive treatment (target hematocrit, <45%) (low-hematocrit group) or less intensive treatment (target hematocrit, 45 to 50%) (high-hematocrit group). The primary composite end point was the time until death from cardiovascular causes or major thrombotic events. The secondary end points were cardiovascula…

MaleHematocritRECURRENT THROMBOSISlaw.inventionAged; Antineoplastic Agents; Cardiovascular Diseases; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hydroxyurea; Janus Kinase 2; Male; Middle Aged; Polycythemia Vera; Thrombosis; Hematocrit; Phlebotomy; Medicine (all)LEUKOCYTOSISPolycythemia veraRandomized controlled trialPhlebotomylawhemic and lymphatic diseasesESSENTIAL THROMBOCYTHEMIAClinical endpointHydroxyureaPolycythemia Vera Secondary ProphylaxisESSENTIAL THROMBOCYTHEMIA RECURRENT THROMBOSIS RISK-FACTOR HEMATOCRIT MANAGEMENT LEUKOCYTOSIS PREVENTION DIAGNOSIS EFFICACY WARFARINPolycythemia Veramedicine.diagnostic_testMedicine (all)Hazard ratioGeneral MedicineMiddle AgedCombined Modality TherapyHematocritCardiovascular DiseasesFemalemedicine.medical_specialtyrandomized trial; polycythemia veraAntineoplastic AgentsCardiovascular eventDIAGNOSISWARFARINRISK-FACTORInternal medicineMANAGEMENTmedicineHumansMyelofibrosisAdverse effectAgedbusiness.industryThrombosisPhlebotomyJanus Kinase 2EFFICACYmedicine.diseasePREVENTIONSurgeryPolycythemia Vera Cardiovascular event hematocritSettore MED/15 - MALATTIE DEL SANGUEbusinessFollow-Up Studies
researchProduct

Erythropoietin and iron therapy for preterm infants

1999

Pediatricsmedicine.medical_specialtyBlood transfusionmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentHematocritPhlebotomyInfant newbornErythropoietinPediatrics Perinatology and Child HealthmedicinebusinessIron therapymedicine.drugThe Journal of Pediatrics
researchProduct

Painful procedures in the NICU

2012

The authors after a brief introduction on the development of the perception of pain in the fetus and newborn, focus attention on the problem of painful procedures that are performed in the neonatal intensive care units reported in the scientific literature. Then report the design of the double-blind study that is taking place from February 2012 at the NICU ARNAS Civic - Palermo using three different concentrations of sucrose as analgesia during venipuncture and heel puncture in term neonates.

Sucrosemedicine.medical_specialtyPediatricsHeelVenipuncturebusiness.industryInfant NewbornPainObstetrics and GynecologyTerm neonatesmedicine.anatomical_structurePhlebotomyIntensive carePediatrics Perinatology and Child HealthIntensive Care NeonatalHumansPain ManagementMedicineHeelAnalgesiabusinessIntensive care medicineThe Journal of Maternal-Fetal &amp; Neonatal Medicine
researchProduct

Distraction as a technique to control pain in pediatric patients during venipuncture. A narrative review of literature

2015

Introduzione: La distrazione è un intervento non farmacologico in grado di ridurre l’intensità del dolore procedurale nei bambini. Tra le procedure maggiormente diffuse, la venipuntura è una di quelle maggiormente applicate in area pediatrica, per scopi diagnostici e terapeutici. L’analgesia durante la venipuntura può essere efficacemente raggiunta con tecniche di distrazione. Obiettivo: descrivere l’efficacia delle tecniche di distrazione attiva e passiva per la riduzione del dolore, nei bambini sottoposti a venipuntura. Metodi: è stata realizzata una revisione della letteratura consultando i database CINHAL, PubMed, ILISI e Cochrane. Sono stati inclusi tutti studi primari e secondari pubb…

child; humans; pain; phlebotomy; psychology child; relaxation therapy; play and playthingschildplay and playthingsnursingphlebotomycomplementary therapierelaxation therapyPsychology ChildpainpsychologyhumansSettore MED/45 - Scienze Infermieristiche Generali Cliniche E Pediatrichedistraction
researchProduct

A Large-Scale Trial Testing the Intensità of CYTOreductive Therapy to prevent Cardiovascular Events in Patients with Polycythemia Vera (CYTO-PV trial…

2012

Abstract Abstract 4 Introduction Current treatment recommendations in polycythemia vera (PV) have emphasized to maintain the hematocrit (HCT) values &lt;0.45 based on hemorrheological notions, results of a few small observational retrospective studies and consensus of experts. However, post-hoc analysis of two large randomized clinical trials (namely PVSG-1 and ECLAP) failed to show a different incidence of major thrombosis when HCT levels were kept in the range between 0.40 and 0.50. So far, no randomized clinical trial has provided evidence-based data assessing the usefulness of tight HCT control in reducing thrombosis. Thus, uncertainty of the optimal HCT target exists in clinical practi…

medicine.medical_specialtyRandomizationmedicine.diagnostic_testbusiness.industrySurrogate endpointImmunologyWarfarinCell BiologyHematologyPhlebotomyHematocritmedicine.diseaseBiochemistrylaw.inventionPolycythemia veraRandomized controlled triallawConcomitantInternal medicineMedicinebusinessmedicine.drug
researchProduct

Mitigando el dolor durante la punción venosa en una población pediátrica: un estudio factorial aleatorizado

2016

medicine.medical_specialtyVenipuncturebusiness.industryMEDLINEGeneral MedicineFactorial experimentPhlebotomylaw.inventionProcedural Pain03 medical and health sciences0302 clinical medicineRandomized controlled triallawPhysical therapymedicine030212 general & internal medicinebusiness030217 neurology & neurosurgeryGeneral NursingPediatric populationEnfermería Clínica
researchProduct